FDA Inspection 1111586 — Camber Pharmaceuticals, Inc
The FDA completed an inspection of Camber Pharmaceuticals, Inc on November 25, 2019 in Piscataway, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 25, 2019
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Piscataway, NJ (United States)